ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 56 filers reported holding ADC THERAPEUTICS SA in Q3 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $67,000 | -45.5% | 13,945 | -10.1% | 0.02% | -41.9% |
Q2 2022 | $123,000 | -46.1% | 15,515 | 0.0% | 0.04% | -39.4% |
Q1 2022 | $228,000 | -26.0% | 15,515 | +1.8% | 0.07% | -12.3% |
Q4 2021 | $308,000 | -23.4% | 15,245 | +3.0% | 0.08% | -25.7% |
Q3 2021 | $402,000 | -3.1% | 14,805 | -13.0% | 0.11% | -6.8% |
Q2 2021 | $415,000 | +8.4% | 17,025 | +8.5% | 0.12% | -0.8% |
Q1 2021 | $383,000 | +11.0% | 15,686 | +45.6% | 0.12% | +9.3% |
Q4 2020 | $345,000 | +47.4% | 10,775 | +52.1% | 0.11% | +25.6% |
Q3 2020 | $234,000 | +2.6% | 7,085 | +45.6% | 0.09% | -4.4% |
Q2 2020 | $228,000 | – | 4,865 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 1,186,215 | $9,430,000 | 5.29% |
GCM Grosvenor Holdings, LLC | 1,298,012 | $10,319,000 | 2.33% |
Redmile Group, LLC | 7,512,029 | $59,721,000 | 2.28% |
MPM BioImpact LLC | 334,384 | $2,658,000 | 0.74% |
Indie Asset Partners, LLC | 93,989 | $747,000 | 0.66% |
Eventide Asset Management | 1,879,959 | $14,946,000 | 0.32% |
Walleye Capital LLC | 888,700 | $7,065,000 | 0.20% |
Endurant Capital Management LP | 58,967 | $469,000 | 0.16% |
HHLR ADVISORS, LTD. | 500,000 | $3,975,000 | 0.08% |
Matrix Capital Management Company, LP | 400,000 | $3,180,000 | 0.07% |